NeoVista Raises $41 Million

NeoVista Inc., a Fremont, Calif.-based ophthalmic device company focused on the treatment of age-related macular degeneration, has raised $41 million in Series C funding. Essex Woodlands Health Ventures led the deal, and was joined by MPM Capital and return backers Versant Ventures, SV Life Sciences, The Carlyle Group and Accuitive Medical Ventures.